These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 21532623

  • 21. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP.
    Oncotarget; 2016 Apr 19; 7(16):22674-86. PubMed ID: 26993767
    [Abstract] [Full Text] [Related]

  • 22. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.
    Int J Oncol; 2014 May 19; 44(5):1643-51. PubMed ID: 24573038
    [Abstract] [Full Text] [Related]

  • 23. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X, Zheng K, Li C, Zhao Y, Li H, Liu X, Long Y, Yao J.
    Oncol Rep; 2017 May 19; 37(5):2847-2856. PubMed ID: 28339056
    [Abstract] [Full Text] [Related]

  • 24. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K.
    Int J Cancer; 2012 Dec 01; 131(11):2537-46. PubMed ID: 22488108
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG.
    J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
    Saito D, Kyakumoto S, Chosa N, Ibi M, Takahashi N, Okubo N, Sawada S, Ishisaki A, Kamo M.
    J Biochem; 2013 Mar 11; 153(3):303-15. PubMed ID: 23248240
    [Abstract] [Full Text] [Related]

  • 29. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z, Zhang Y, Sun XX, Ma X, Chen ZN.
    Mol Cancer; 2015 Jan 21; 14():5. PubMed ID: 25608619
    [Abstract] [Full Text] [Related]

  • 30. Enhanced expression of Hab18g/CD147 and activation of integrin pathway in HCC cells under 3-D co-culture conditions.
    Wu YM, Tang J, Zhao P, Chen ZN, Jiang JL.
    Cell Biol Int; 2009 Feb 21; 33(2):199-206. PubMed ID: 19059491
    [Abstract] [Full Text] [Related]

  • 31. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.
    Caja L, Bertran E, Campbell J, Fausto N, Fabregat I.
    J Cell Physiol; 2011 May 21; 226(5):1214-23. PubMed ID: 20945437
    [Abstract] [Full Text] [Related]

  • 32. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J.
    Cancer Lett; 2015 Mar 28; 358(2):124-135. PubMed ID: 25462858
    [Abstract] [Full Text] [Related]

  • 33. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
    Xia W, Ma X, Li X, Dong H, Yi J, Zeng W, Yang Z.
    Oncol Rep; 2015 Aug 28; 34(2):655-62. PubMed ID: 26035427
    [Abstract] [Full Text] [Related]

  • 34. DNAJC6 promotes hepatocellular carcinoma progression through induction of epithelial-mesenchymal transition.
    Yang T, Li XN, Li XG, Li M, Gao PZ.
    Biochem Biophys Res Commun; 2014 Dec 12; 455(3-4):298-304. PubMed ID: 25446072
    [Abstract] [Full Text] [Related]

  • 35. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J, Lu M, Li Y, Shang YK, Wang SJ, Meng Y, Wang Z, Li ZS, Chen H, Chen ZN, Bian H.
    Oncogene; 2016 Oct 20; 35(42):5468-5479. PubMed ID: 27041581
    [Abstract] [Full Text] [Related]

  • 36. CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC.
    Li H, Wang S, Li X, Weng Y, Guo D, Kong P, Cheng C, Wang Y, Zhang L, Cheng X, Cui Y.
    Cancer Sci; 2023 Jan 20; 114(1):91-104. PubMed ID: 36056599
    [Abstract] [Full Text] [Related]

  • 37. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z, Zhang Y, Xu Z.
    J BUON; 2018 Jan 20; 23(1):188-192. PubMed ID: 29552782
    [Abstract] [Full Text] [Related]

  • 38. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q, Fan M, Wang J, Ullah A, Ghauri MA, Dai B, Zhan Y, Zhang D, Zhang Y.
    Cell Death Dis; 2019 Dec 09; 10(12):939. PubMed ID: 31819036
    [Abstract] [Full Text] [Related]

  • 39. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Li Y, Zhu X, Zeng Y, Wang J, Zhang X, Ding YQ, Liang L.
    Mol Cancer Res; 2010 Dec 09; 8(12):1579-90. PubMed ID: 21071512
    [Abstract] [Full Text] [Related]

  • 40. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
    Wang H, Xu L, Zhu X, Wang P, Chi H, Meng Z.
    Oncol Rep; 2014 Oct 09; 32(4):1465-72. PubMed ID: 25070581
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.